Abstract

Presentation slides on Incremental Cost-Effectiveness of the 9-valent vs. the 4-valent HPV vaccine in the U.S. for the October 2014 ACIP meeting.

  • Background paper
  • Americas
  • United States of America
  • Human papillomavirus (HPV)